About 454 Life Sciences
454 Life Sciences is a Healthcare company based in Branford (United States) founded in 2005, and was acquired by Roche in March 2007. Provider of genome and DNA sequencing instruments for life sciences. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity is 454 LIFE SCIENCES CORPORATION. Its competitors include 10X Genomics, PacBio and Omniome; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2005, instruments for genome and DNA sequencing are provided by the company in the life sciences sector. Operations focus on de novo sequencing and resequencing of whole genomes, targeted resequencing of specific genomic regions, metagenomics, transcriptome sequencing, and methylation analysis. The company is based in Branford, United States, serving research and analytical needs in genomics.
Investors in 454 Life Sciences
454 Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Roche.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland |
Investor details for 454 Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of 454 Life Sciences
2 dated milestones of 454 Life Sciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded 454 Life Sciences is founded.
- Exit Acquired by Roche.
Competitors of 454 Life Sciences
454 Life Sciences has 3 listed competitors in our database, 3 of them funded. They include 10X Genomics, PacBio and Omniome.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. |
Detailed competitors of 454 Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 454 Life Sciences
Websites that share an audience with 454 Life Sciences (454.com).
Websites whose visitors overlap most with 454 Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
en.wikipedia.org | en.wikipedia.org | 100% | – | ||
| illumina.com | 100% | 672.7K | #61,793 | View details | |
| biomatters.com | 98% | View details | |||
my454.com | my454.com | 94% | – | ||
pacificbiosciences.com | pacificbiosciences.com | 69% | #1,479,936 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for 454 Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as 454 Life Sciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 454 Life Sciences
454 Life Sciences was founded in 2005.
454 Life Sciences is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
Founded in 2005, instruments for genome and DNA sequencing are provided by the company in the life sciences sector. Operations focus on de novo sequencing and resequencing of whole genomes, targeted resequencing of specific genomic regions, metagenomics, transcriptome sequencing, and methylation analysis. The company is based in Branford, United States, serving research and analytical needs in genomics.
454 Life Sciences's top competitors include 10X Genomics, PacBio and Omniome.
454 Life Sciences has 1 investor. Key investors include Roche.
454 Life Sciences operates through 454 Life Sciences Corporation.
Yes. 454 Life Sciences was acquired by Roche in March 2007.